Background The development of systemic treatment options leveraging the molecular
landscape of advanced thyroid cancer is a burgeoning field. This is a multidisciplinary …

Simple Summary Only about 4% of thyroid nodules are carcinomas and require surgery.
Fine-needle aspiration cytology is the most accurate tool to distinguish benign from …

Background Papillary thyroid carcinoma (PTC) can be classified into two distinct molecular
subtypes, BRAF-like (BL) and RAS-like (RL). However, the molecular characteristics of each …

Since Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP)
was introduced as a new thyroid tumour entity, many studies, and meta-analyses on …

Papillary thyroid cancer is the most common endocrine malignancy, occurring at an
incidence rate of 12.9 per 100,000 in the US adult population. While the overall 10-year …

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a
borderline thyroid tumour formerly known as noninvasive encapsulated follicular variant of …

Since the release of The Cancer Genome Atlas study of papillary thyroid carcinoma (PTC) in
2014, additional genomic studies of differentiated thyroid carcinoma (DTC) using massively …

Thyroid cancer is the most prevalent endocrine malignancy in the United States with greater
than 53,000 new cases in 2020. There is a significant gender disparity in disease incidence …

More than 70 years ago, Prof. Pierre Masson, a renowned French-Canadian pathologist
(1880–1959), advised us that “No classification is more difficult to establish than that of …

The noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a
strictly defined thyroid lesion, reclassified in 2016, in order to more accurately reflect the …